APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Complement C5 Recombinant Monoclonal Antibody

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Complement C5 Recombinant Monoclonal Antibody Market Analysis and Forecast 2026-2032

Report ID 173980150229 December 2025198 pages

Choose your research edition.

Industry ResearchComplement C5 Recombinant Monoclonal Antibody Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Complement C5 Recombinant Monoclonal Antibody Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Complement C5 Recombinant Monoclonal Antibody Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Complement C5 Recombinant Monoclonal Antibody Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Complement C5 Recombinant Monoclonal Antibody Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Complement C5 Recombinant Monoclonal Antibody market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Complement C5 Recombinant Monoclonal Antibody is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Complement C5 Recombinant Monoclonal Antibody is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Complement C5 Recombinant Monoclonal Antibody is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Complement C5 Recombinant Monoclonal Antibody is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Complement C5 Recombinant Monoclonal Antibody include Alexion Pharmaceuticals, Regeneron Pharmaceuticals, Amgen, Roche and Samsung Bioepis, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Complement C5 Recombinant Monoclonal Antibody, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Complement C5 Recombinant Monoclonal Antibody, also provides the sales of main regions and countries. Of the upcoming market potential for Complement C5 Recombinant Monoclonal Antibody, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Complement C5 Recombinant Monoclonal Antibody sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Complement C5 Recombinant Monoclonal Antibody market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Complement C5 Recombinant Monoclonal Antibody sales, projected growth trends, production technology, application and end-user industry.

Complement C5 Recombinant Monoclonal Antibody Segment by Company

Alexion Pharmaceuticals

Regeneron Pharmaceuticals

Amgen

Roche

Samsung Bioepis

Complement C5 Recombinant Monoclonal Antibody Segment by Type

Eculizumab

Pozelimab

Ravulizumab

Crovalimab

Others

Complement C5 Recombinant Monoclonal Antibody Segment by Application

PNH

CD55 Deficiency

aHUS

Others

Complement C5 Recombinant Monoclonal Antibody Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Complement C5 Recombinant Monoclonal Antibody market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Complement C5 Recombinant Monoclonal Antibody and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Complement C5 Recombinant Monoclonal Antibody.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Complement C5 Recombinant Monoclonal Antibody in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Complement C5 Recombinant Monoclonal Antibody manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Complement C5 Recombinant Monoclonal Antibody sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Complement C5 Recombinant Monoclonal Antibody Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Eculizumab Major Manufacturers Table 3. Pozelimab Major Manufacturers Table 4. Ravulizumab Major Manufacturers Table 5. Crovalimab Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Complement C5 Recombinant Monoclonal Antibody Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. PNH Major Manufacturers Table 9. CD55 Deficiency Major Manufacturers Table 10. aHUS Major Manufacturers Table 11. Others Major Manufacturers Table 12. Complement C5 Recombinant Monoclonal Antibody Industry Trends Table 13. Complement C5 Recombinant Monoclonal Antibody Industry Drivers Table 14. Complement C5 Recombinant Monoclonal Antibody Industry Opportunities and Challenges Table 15. Complement C5 Recombinant Monoclonal Antibody Industry Restraints Table 16. Global Complement C5 Recombinant Monoclonal Antibody Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Complement C5 Recombinant Monoclonal Antibody Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Complement C5 Recombinant Monoclonal Antibody Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Region (2021-2026) Table 20. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Region (2027-2032) Table 21. Global Complement C5 Recombinant Monoclonal Antibody Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 22. Global Complement C5 Recombinant Monoclonal Antibody Sales by Region (2021-2026) & (K Units) Table 23. Global Complement C5 Recombinant Monoclonal Antibody Sales by Region (2027-2032) & (K Units) Table 24. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Region (2021-2026) Table 25. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Region (2027-2032) Table 26. Global Complement C5 Recombinant Monoclonal Antibody Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Complement C5 Recombinant Monoclonal Antibody Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Manufacturers (2021-2026) Table 30. Global Complement C5 Recombinant Monoclonal Antibody Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 31. Global Complement C5 Recombinant Monoclonal Antibody Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Complement C5 Recombinant Monoclonal Antibody Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Complement C5 Recombinant Monoclonal Antibody Manufacturers, Product Type & Application Table 34. Global Complement C5 Recombinant Monoclonal Antibody Manufacturers' Establishment Date Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Complement C5 Recombinant Monoclonal Antibody by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 37. Global Complement C5 Recombinant Monoclonal Antibody Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Complement C5 Recombinant Monoclonal Antibody Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Complement C5 Recombinant Monoclonal Antibody Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Type (2021-2026) Table 41. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Type (2027-2032) Table 42. Global Complement C5 Recombinant Monoclonal Antibody Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 43. Global Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021-2026) & (K Units) Table 44. Global Complement C5 Recombinant Monoclonal Antibody Sales by Type (2027-2032) & (K Units) Table 45. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Type (2021-2026) Table 46. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Type (2027-2032) Table 47. Global Complement C5 Recombinant Monoclonal Antibody Price by Type (2021-2026) & (US$/Unit) Table 48. Global Complement C5 Recombinant Monoclonal Antibody Price by Type (2027-2032) & (US$/Unit) Table 49. Global Complement C5 Recombinant Monoclonal Antibody Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Complement C5 Recombinant Monoclonal Antibody Revenue by Application (2021-2026) & (US$ Million) Table 51. Global Complement C5 Recombinant Monoclonal Antibody Revenue by Application (2027-2032) & (US$ Million) Table 52. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Application (2021-2026) Table 53. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Application (2027-2032) Table 54. Global Complement C5 Recombinant Monoclonal Antibody Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 55. Global Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021-2026) & (K Units) Table 56. Global Complement C5 Recombinant Monoclonal Antibody Sales by Application (2027-2032) & (K Units) Table 57. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Application (2021-2026) Table 58. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Application (2027-2032) Table 59. Global Complement C5 Recombinant Monoclonal Antibody Price by Application (2021-2026) & (US$/Unit) Table 60. Global Complement C5 Recombinant Monoclonal Antibody Price by Application (2027-2032) & (US$/Unit) Table 61. Alexion Pharmaceuticals Company Information Table 62. Alexion Pharmaceuticals Business Overview Table 63. Alexion Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Alexion Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Product Portfolio Table 65. Alexion Pharmaceuticals Recent Development Table 66. Regeneron Pharmaceuticals Company Information Table 67. Regeneron Pharmaceuticals Business Overview Table 68. Regeneron Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Regeneron Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Product Portfolio Table 70. Regeneron Pharmaceuticals Recent Development Table 71. Amgen Company Information Table 72. Amgen Business Overview Table 73. Amgen Complement C5 Recombinant Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Amgen Complement C5 Recombinant Monoclonal Antibody Product Portfolio Table 75. Amgen Recent Development Table 76. Roche Company Information Table 77. Roche Business Overview Table 78. Roche Complement C5 Recombinant Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Roche Complement C5 Recombinant Monoclonal Antibody Product Portfolio Table 80. Roche Recent Development Table 81. Samsung Bioepis Company Information Table 82. Samsung Bioepis Business Overview Table 83. Samsung Bioepis Complement C5 Recombinant Monoclonal Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Samsung Bioepis Complement C5 Recombinant Monoclonal Antibody Product Portfolio Table 85. Samsung Bioepis Recent Development Table 86. North America Complement C5 Recombinant Monoclonal Antibody Revenue by Type (2021-2026) & (US$ Million) Table 87. North America Complement C5 Recombinant Monoclonal Antibody Revenue by Type (2027-2032) & (US$ Million) Table 88. North America Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021-2026) & (K Units) Table 89. North America Complement C5 Recombinant Monoclonal Antibody Sales by Type (2027-2032) & (K Units) Table 90. North America Complement C5 Recombinant Monoclonal Antibody Sales Price by Type (2021-2026) & (US$/Unit) Table 91. North America Complement C5 Recombinant Monoclonal Antibody Sales Price by Type (2027-2032) & (US$/Unit) Table 92. North America Complement C5 Recombinant Monoclonal Antibody Revenue by Application (2021-2026) & (US$ Million) Table 93. North America Complement C5 Recombinant Monoclonal Antibody Revenue by Application (2027-2032) & (US$ Million) Table 94. North America Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021-2026) & (K Units) Table 95. North America Complement C5 Recombinant Monoclonal Antibody Sales by Application (2027-2032) & (K Units) Table 96. North America Complement C5 Recombinant Monoclonal Antibody Sales Price by Application (2021-2026) & (US$/Unit) Table 97. North America Complement C5 Recombinant Monoclonal Antibody Sales Price by Application (2027-2032) & (US$/Unit) Table 98. North America Complement C5 Recombinant Monoclonal Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. North America Complement C5 Recombinant Monoclonal Antibody Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 100. North America Complement C5 Recombinant Monoclonal Antibody Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 101. North America Complement C5 Recombinant Monoclonal Antibody Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 102. North America Complement C5 Recombinant Monoclonal Antibody Sales by Country (2021-2026) & (K Units) Table 103. North America Complement C5 Recombinant Monoclonal Antibody Sales by Country (2027-2032) & (K Units) Table 104. North America Complement C5 Recombinant Monoclonal Antibody Sales Price by Country (2021-2026) & (US$/Unit) Table 105. North America Complement C5 Recombinant Monoclonal Antibody Sales Price by Country (2027-2032) & (US$/Unit) Table 106. United States Complement C5 Recombinant Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 107. Canada Complement C5 Recombinant Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 108. Mexico Complement C5 Recombinant Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 109. Europe Complement C5 Recombinant Monoclonal Antibody Revenue by Type (2021-2026) & (US$ Million) Table 110. Europe Complement C5 Recombinant Monoclonal Antibody Revenue by Type (2027-2032) & (US$ Million) Table 111. Europe Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021-2026) & (K Units) Table 112. Europe Complement C5 Recombinant Monoclonal Antibody Sales by Type (2027-2032) & (K Units) Table 113. Europe Complement C5 Recombinant Monoclonal Antibody Sales Price by Type (2021-2026) & (US$/Unit) Table 114. Europe Complement C5 Recombinant Monoclonal Antibody Sales Price by Type (2027-2032) & (US$/Unit) Table 115. Europe Complement C5 Recombinant Monoclonal Antibody Revenue by Application (2021-2026) & (US$ Million) Table 116. Europe Complement C5 Recombinant Monoclonal Antibody Revenue by Application (2027-2032) & (US$ Million) Table 117. Europe Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021-2026) & (K Units) Table 118. Europe Complement C5 Recombinant Monoclonal Antibody Sales by Application (2027-2032) & (K Units) Table 119. Europe Complement C5 Recombinant Monoclonal Antibody Sales Price by Application (2021-2026) & (US$/Unit) Table 120. Europe Complement C5 Recombinant Monoclonal Antibody Sales Price by Application (2027-2032) & (US$/Unit) Table 121. Europe Complement C5 Recombinant Monoclonal Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Europe Complement C5 Recombinant Monoclonal Antibody Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 123. Europe Complement C5 Recombinant Monoclonal Antibody Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 124. Europe Complement C5 Recombinant Monoclonal Antibody Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 125. Europe Complement C5 Recombinant Monoclonal Antibody Sales by Country (2021-2026) & (K Units) Table 126. Europe Complement C5 Recombinant Monoclonal Antibody Sales by Country (2027-2032) & (K Units) Table 127. Europe Complement C5 Recombinant Monoclonal Antibody Sales Price by Country (2021-2026) & (US$/Unit) Table 128. Europe Complement C5 Recombinant Monoclonal Antibody Sales Price by Country (2027-2032) & (US$/Unit) Table 129. Germany Complement C5 Recombinant Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 130. France Complement C5 Recombinant Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 131. U.K. Complement C5 Recombinant Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 132. Italy Complement C5 Recombinant Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 133. Russia Complement C5 Recombinant Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 134. Spain Complement C5 Recombinant Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 135. Netherlands Complement C5 Recombinant Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 136. Switzerland Complement C5 Recombinant Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 137. Sweden Complement C5 Recombinant Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 138. Poland Complement C5 Recombinant Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 139. China Complement C5 Recombinant Monoclonal Antibody Revenue by Type (2021-2026) & (US$ Million) Table 140. China Complement C5 Recombinant Monoclonal Antibody Revenue by Type (2027-2032) & (US$ Million) Table 141. China Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021-2026) & (K Units) Table 142. China Complement C5 Recombinant Monoclonal Antibody Sales by Type (2027-2032) & (K Units) Table 143. China Complement C5 Recombinant Monoclonal Antibody Sales Price by Type (2021-2026) & (US$/Unit) Table 144. China Complement C5 Recombinant Monoclonal Antibody Sales Price by Type (2027-2032) & (US$/Unit) Table 145. China Complement C5 Recombinant Monoclonal Antibody Revenue by Application (2021-2026) & (US$ Million) Table 146. China Complement C5 Recombinant Monoclonal Antibody Revenue by Application (2027-2032) & (US$ Million) Table 147. China Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021-2026) & (K Units) Table 148. China Complement C5 Recombinant Monoclonal Antibody Sales by Application (2027-2032) & (K Units) Table 149. China Complement C5 Recombinant Monoclonal Antibody Sales Price by Application (2021-2026) & (US$/Unit) Table 150. China Complement C5 Recombinant Monoclonal Antibody Sales Price by Application (2027-2032) & (US$/Unit) Table 151. Asia Complement C5 Recombinant Monoclonal Antibody Revenue by Type (2021-2026) & (US$ Million) Table 152. Asia Complement C5 Recombinant Monoclonal Antibody Revenue by Type (2027-2032) & (US$ Million) Table 153. Asia Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021-2026) & (K Units) Table 154. Asia Complement C5 Recombinant Monoclonal Antibody Sales by Type (2027-2032) & (K Units) Table 155. Asia Complement C5 Recombinant Monoclonal Antibody Sales Price by Type (2021-2026) & (US$/Unit) Table 156. Asia Complement C5 Recombinant Monoclonal Antibody Sales Price by Type (2027-2032) & (US$/Unit) Table 157. Asia Complement C5 Recombinant Monoclonal Antibody Revenue by Application (2021-2026) & (US$ Million) Table 158. Asia Complement C5 Recombinant Monoclonal Antibody Revenue by Application (2027-2032) & (US$ Million) Table 159. Asia Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021-2026) & (K Units) Table 160. Asia Complement C5 Recombinant Monoclonal Antibody Sales by Application (2027-2032) & (K Units) Table 161. Asia Complement C5 Recombinant Monoclonal Antibody Sales Price by Application (2021-2026) & (US$/Unit) Table 162. Asia Complement C5 Recombinant Monoclonal Antibody Sales Price by Application (2027-2032) & (US$/Unit) Table 163. Asia Complement C5 Recombinant Monoclonal Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 164. Asia Complement C5 Recombinant Monoclonal Antibody Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 165. Asia Complement C5 Recombinant Monoclonal Antibody Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 166. Asia Complement C5 Recombinant Monoclonal Antibody Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 167. Asia Complement C5 Recombinant Monoclonal Antibody Sales by Country (2021-2026) & (K Units) Table 168. Asia Complement C5 Recombinant Monoclonal Antibody Sales by Country (2027-2032) & (K Units) Table 169. Asia Complement C5 Recombinant Monoclonal Antibody Sales Price by Country (2021-2026) & (US$/Unit) Table 170. Asia Complement C5 Recombinant Monoclonal Antibody Sales Price by Country (2027-2032) & (US$/Unit) Table 171. Japan Complement C5 Recombinant Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 172. South Korea Complement C5 Recombinant Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 173. India Complement C5 Recombinant Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 174. Australia Complement C5 Recombinant Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 175. Taiwan Complement C5 Recombinant Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 176. Southeast Asia Complement C5 Recombinant Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 177. SAMEA Complement C5 Recombinant Monoclonal Antibody Revenue by Type (2021-2026) & (US$ Million) Table 178. SAMEA Complement C5 Recombinant Monoclonal Antibody Revenue by Type (2027-2032) & (US$ Million) Table 179. SAMEA Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021-2026) & (K Units) Table 180. SAMEA Complement C5 Recombinant Monoclonal Antibody Sales by Type (2027-2032) & (K Units) Table 181. SAMEA Complement C5 Recombinant Monoclonal Antibody Sales Price by Type (2021-2026) & (US$/Unit) Table 182. SAMEA Complement C5 Recombinant Monoclonal Antibody Sales Price by Type (2027-2032) & (US$/Unit) Table 183. SAMEA Complement C5 Recombinant Monoclonal Antibody Revenue by Application (2021-2026) & (US$ Million) Table 184. SAMEA Complement C5 Recombinant Monoclonal Antibody Revenue by Application (2027-2032) & (US$ Million) Table 185. SAMEA Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021-2026) & (K Units) Table 186. SAMEA Complement C5 Recombinant Monoclonal Antibody Sales by Application (2027-2032) & (K Units) Table 187. SAMEA Complement C5 Recombinant Monoclonal Antibody Sales Price by Application (2021-2026) & (US$/Unit) Table 188. SAMEA Complement C5 Recombinant Monoclonal Antibody Sales Price by Application (2027-2032) & (US$/Unit) Table 189. SAMEA Complement C5 Recombinant Monoclonal Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 190. SAMEA Complement C5 Recombinant Monoclonal Antibody Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 191. SAMEA Complement C5 Recombinant Monoclonal Antibody Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 192. SAMEA Complement C5 Recombinant Monoclonal Antibody Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 193. SAMEA Complement C5 Recombinant Monoclonal Antibody Sales by Country (2021-2026) & (K Units) Table 194. SAMEA Complement C5 Recombinant Monoclonal Antibody Sales by Country (2027-2032) & (K Units) Table 195. SAMEA Complement C5 Recombinant Monoclonal Antibody Sales Price by Country (2021-2026) & (US$/Unit) Table 196. SAMEA Complement C5 Recombinant Monoclonal Antibody Sales Price by Country (2027-2032) & (US$/Unit) Table 197. Brazil Complement C5 Recombinant Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 198. Argentina Complement C5 Recombinant Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 199. Chile Complement C5 Recombinant Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 200. Colombia Complement C5 Recombinant Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 201. Peru Complement C5 Recombinant Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 202. Saudi Arabia Complement C5 Recombinant Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 203. Israel Complement C5 Recombinant Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 204. UAE Complement C5 Recombinant Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 205. Turkey Complement C5 Recombinant Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 206. Iran Complement C5 Recombinant Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 207. Egypt Complement C5 Recombinant Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Table 208. Key Raw Materials Table 209. Raw Materials Key Suppliers Table 210. Complement C5 Recombinant Monoclonal Antibody Distributors List Table 211. Complement C5 Recombinant Monoclonal Antibody Customers List Table 212. Research Programs/Design for This Report Table 213. Authors List of This Report Table 214. Secondary Sources Table 215. Primary Sources List of Figures Figure 1. Complement C5 Recombinant Monoclonal Antibody Image Figure 2. Global Complement C5 Recombinant Monoclonal Antibody Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Complement C5 Recombinant Monoclonal Antibody Market Size Share 2021 VS 2025 VS 2032 Figure 4. Eculizumab Image Figure 5. Pozelimab Image Figure 6. Ravulizumab Image Figure 7. Crovalimab Image Figure 8. Others Image Figure 9. Global Complement C5 Recombinant Monoclonal Antibody Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Complement C5 Recombinant Monoclonal Antibody Market Size Share 2021 VS 2025 VS 2032 Figure 11. PNH Image Figure 12. CD55 Deficiency Image Figure 13. aHUS Image Figure 14. Others Image Figure 15. Global Complement C5 Recombinant Monoclonal Antibody Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Complement C5 Recombinant Monoclonal Antibody Revenue (2021-2032) & (US$ Million) Figure 17. Global Complement C5 Recombinant Monoclonal Antibody Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Region (2021-2032) Figure 20. Global Complement C5 Recombinant Monoclonal Antibody Sales (2021-2032) & (K Units) Figure 21. Global Complement C5 Recombinant Monoclonal Antibody Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 22. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Region (2021-2032) Figure 23. US & Canada & Mexico Complement C5 Recombinant Monoclonal Antibody Sales YoY (2021-2032) & (K Units) Figure 24. Europe Complement C5 Recombinant Monoclonal Antibody Sales YoY (2021-2032) & (K Units) Figure 25. China Complement C5 Recombinant Monoclonal Antibody Sales YoY (2021-2032) & (K Units) Figure 26. Asia (Excluding China) Complement C5 Recombinant Monoclonal Antibody Sales YoY (2021-2032) & (K Units) Figure 27. South America, Middle East and Africa Complement C5 Recombinant Monoclonal Antibody Sales YoY (2021-2032) & (K Units) Figure 28. Global Complement C5 Recombinant Monoclonal Antibody Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Complement C5 Recombinant Monoclonal Antibody Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Complement C5 Recombinant Monoclonal Antibody Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 32. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Type (2021-2032) Figure 34. Global Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 35. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Type (2021-2032) Figure 37. Global Complement C5 Recombinant Monoclonal Antibody Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 38. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Application (2021-2032) Figure 40. Global Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 41. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Application (2021-2032) Figure 43. North America Complement C5 Recombinant Monoclonal Antibody Revenue Share by Type (2021-2032) Figure 44. North America Complement C5 Recombinant Monoclonal Antibody Sales Share by Type (2021-2032) Figure 45. North America Complement C5 Recombinant Monoclonal Antibody Revenue Share by Application (2021-2032) Figure 46. North America Complement C5 Recombinant Monoclonal Antibody Sales Share by Application (2021-2032) Figure 47. North America Complement C5 Recombinant Monoclonal Antibody Revenue Share by Country (2021-2032) Figure 48. North America Complement C5 Recombinant Monoclonal Antibody Sales Share by Country (2021-2032) Figure 49. Europe Complement C5 Recombinant Monoclonal Antibody Revenue Share by Type (2021-2032) Figure 50. Europe Complement C5 Recombinant Monoclonal Antibody Sales Share by Type (2021-2032) Figure 51. Europe Complement C5 Recombinant Monoclonal Antibody Revenue Share by Application (2021-2032) Figure 52. Europe Complement C5 Recombinant Monoclonal Antibody Sales Share by Application (2021-2032) Figure 53. Europe Complement C5 Recombinant Monoclonal Antibody Revenue Share by Country (2021-2032) Figure 54. Europe Complement C5 Recombinant Monoclonal Antibody Sales Share by Country (2021-2032) Figure 55. China Complement C5 Recombinant Monoclonal Antibody Revenue Share by Type (2021-2032) Figure 56. China Complement C5 Recombinant Monoclonal Antibody Sales Share by Type (2021-2032) Figure 57. China Complement C5 Recombinant Monoclonal Antibody Revenue Share by Application (2021-2032) Figure 58. China Complement C5 Recombinant Monoclonal Antibody Sales Share by Application (2021-2032) Figure 59. Asia Complement C5 Recombinant Monoclonal Antibody Revenue Share by Type (2021-2032) Figure 60. Asia Complement C5 Recombinant Monoclonal Antibody Sales Share by Type (2021-2032) Figure 61. Asia Complement C5 Recombinant Monoclonal Antibody Revenue Share by Application (2021-2032) Figure 62. Asia Complement C5 Recombinant Monoclonal Antibody Sales Share by Application (2021-2032) Figure 63. Asia Complement C5 Recombinant Monoclonal Antibody Revenue Share by Country (2021-2032) Figure 64. Asia Complement C5 Recombinant Monoclonal Antibody Sales Share by Country (2021-2032) Figure 65. SAMEA Complement C5 Recombinant Monoclonal Antibody Revenue Share by Type (2021-2032) Figure 66. SAMEA Complement C5 Recombinant Monoclonal Antibody Sales Share by Type (2021-2032) Figure 67. SAMEA Complement C5 Recombinant Monoclonal Antibody Revenue Share by Application (2021-2032) Figure 68. SAMEA Complement C5 Recombinant Monoclonal Antibody Sales Share by Application (2021-2032) Figure 69. SAMEA Complement C5 Recombinant Monoclonal Antibody Revenue Share by Country (2021-2032) Figure 70. SAMEA Complement C5 Recombinant Monoclonal Antibody Sales Share by Country (2021-2032) Figure 71. Complement C5 Recombinant Monoclonal Antibody Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Complement C5 Recombinant Monoclonal Antibody Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Eculizumab
  • Pozelimab
  • Ravulizumab
  • Crovalimab
  • Others
Applications
  • PNH
  • CD55 Deficiency
  • aHUS
  • Others
Companies covered
  • Alexion Pharmaceuticals
  • Regeneron Pharmaceuticals
  • Amgen
  • Roche
  • Samsung Bioepis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Complement C5 Recombinant Monoclonal Antibody Market by Type
  3. 1.2.1 Global Complement C5 Recombinant Monoclonal Antibody Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Eculizumab
  5. 1.2.3 Pozelimab
  6. 1.2.4 Ravulizumab
  7. 1.2.5 Crovalimab
  8. 1.2.6 Others
  9. 1.3 Complement C5 Recombinant Monoclonal Antibody Market by Application
  10. 1.3.1 Global Complement C5 Recombinant Monoclonal Antibody Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 PNH
  12. 1.3.3 CD55 Deficiency
  13. 1.3.4 aHUS
  14. 1.3.5 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Complement C5 Recombinant Monoclonal Antibody Market Dynamics
  1. 2.1 Complement C5 Recombinant Monoclonal Antibody Industry Trends
  2. 2.2 Complement C5 Recombinant Monoclonal Antibody Industry Drivers
  3. 2.3 Complement C5 Recombinant Monoclonal Antibody Industry Opportunities and Challenges
  4. 2.4 Complement C5 Recombinant Monoclonal Antibody Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Complement C5 Recombinant Monoclonal Antibody Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Complement C5 Recombinant Monoclonal Antibody Revenue by Region
  3. 3.2.1 Global Complement C5 Recombinant Monoclonal Antibody Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Complement C5 Recombinant Monoclonal Antibody Revenue by Region (2021-2026)
  5. 3.2.3 Global Complement C5 Recombinant Monoclonal Antibody Revenue by Region (2027-2032)
  6. 3.2.4 Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Complement C5 Recombinant Monoclonal Antibody Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Complement C5 Recombinant Monoclonal Antibody Sales by Region
  9. 3.4.1 Global Complement C5 Recombinant Monoclonal Antibody Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Complement C5 Recombinant Monoclonal Antibody Sales by Region (2021-2026)
  11. 3.4.3 Global Complement C5 Recombinant Monoclonal Antibody Sales by Region (2027-2032)
  12. 3.4.4 Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Complement C5 Recombinant Monoclonal Antibody Revenue by Manufacturers
  2. 4.1.1 Global Complement C5 Recombinant Monoclonal Antibody Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Complement C5 Recombinant Monoclonal Antibody Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Complement C5 Recombinant Monoclonal Antibody Sales by Manufacturers
  6. 4.2.1 Global Complement C5 Recombinant Monoclonal Antibody Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Complement C5 Recombinant Monoclonal Antibody Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Complement C5 Recombinant Monoclonal Antibody Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Complement C5 Recombinant Monoclonal Antibody Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Complement C5 Recombinant Monoclonal Antibody Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Complement C5 Recombinant Monoclonal Antibody Manufacturers, Product Type & Application
  13. 4.7 Global Complement C5 Recombinant Monoclonal Antibody Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Complement C5 Recombinant Monoclonal Antibody Market CR5 and HHI
  16. 4.8.2 2025 Complement C5 Recombinant Monoclonal Antibody Tier 1, Tier 2, and Tier 3
5 Complement C5 Recombinant Monoclonal Antibody Market by Type
  1. 5.1 Global Complement C5 Recombinant Monoclonal Antibody Revenue by Type
  2. 5.1.1 Global Complement C5 Recombinant Monoclonal Antibody Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Complement C5 Recombinant Monoclonal Antibody Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Complement C5 Recombinant Monoclonal Antibody Sales by Type
  6. 5.2.1 Global Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Type (2021-2032)
  9. 5.3 Global Complement C5 Recombinant Monoclonal Antibody Price by Type
6 Complement C5 Recombinant Monoclonal Antibody Market by Application
  1. 6.1 Global Complement C5 Recombinant Monoclonal Antibody Revenue by Application
  2. 6.1.1 Global Complement C5 Recombinant Monoclonal Antibody Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Complement C5 Recombinant Monoclonal Antibody Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Complement C5 Recombinant Monoclonal Antibody Sales by Application
  6. 6.2.1 Global Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Application (2021-2032)
  9. 6.3 Global Complement C5 Recombinant Monoclonal Antibody Price by Application
7 Company Profiles
  1. 7.1 Alexion Pharmaceuticals
  2. 7.1.1 Alexion Pharmaceuticals Company Information
  3. 7.1.2 Alexion Pharmaceuticals Business Overview
  4. 7.1.3 Alexion Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Alexion Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Product Portfolio
  6. 7.1.5 Alexion Pharmaceuticals Recent Developments
  7. 7.2 Regeneron Pharmaceuticals
  8. 7.2.1 Regeneron Pharmaceuticals Company Information
  9. 7.2.2 Regeneron Pharmaceuticals Business Overview
  10. 7.2.3 Regeneron Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Regeneron Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Product Portfolio
  12. 7.2.5 Regeneron Pharmaceuticals Recent Developments
  13. 7.3 Amgen
  14. 7.3.1 Amgen Company Information
  15. 7.3.2 Amgen Business Overview
  16. 7.3.3 Amgen Complement C5 Recombinant Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Amgen Complement C5 Recombinant Monoclonal Antibody Product Portfolio
  18. 7.3.5 Amgen Recent Developments
  19. 7.4 Roche
  20. 7.4.1 Roche Company Information
  21. 7.4.2 Roche Business Overview
  22. 7.4.3 Roche Complement C5 Recombinant Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Roche Complement C5 Recombinant Monoclonal Antibody Product Portfolio
  24. 7.4.5 Roche Recent Developments
  25. 7.5 Samsung Bioepis
  26. 7.5.1 Samsung Bioepis Company Information
  27. 7.5.2 Samsung Bioepis Business Overview
  28. 7.5.3 Samsung Bioepis Complement C5 Recombinant Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Samsung Bioepis Complement C5 Recombinant Monoclonal Antibody Product Portfolio
  30. 7.5.5 Samsung Bioepis Recent Developments
8 North America
  1. 8.1 North America Complement C5 Recombinant Monoclonal Antibody Market Size by Type
  2. 8.1.1 North America Complement C5 Recombinant Monoclonal Antibody Revenue by Type (2021-2032)
  3. 8.1.2 North America Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021-2032)
  4. 8.1.3 North America Complement C5 Recombinant Monoclonal Antibody Price by Type (2021-2032)
  5. 8.2 North America Complement C5 Recombinant Monoclonal Antibody Market Size by Application
  6. 8.2.1 North America Complement C5 Recombinant Monoclonal Antibody Revenue by Application (2021-2032)
  7. 8.2.2 North America Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021-2032)
  8. 8.2.3 North America Complement C5 Recombinant Monoclonal Antibody Price by Application (2021-2032)
  9. 8.3 North America Complement C5 Recombinant Monoclonal Antibody Market Size by Country
  10. 8.3.1 North America Complement C5 Recombinant Monoclonal Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Complement C5 Recombinant Monoclonal Antibody Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Complement C5 Recombinant Monoclonal Antibody Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Complement C5 Recombinant Monoclonal Antibody Market Size by Type
  2. 9.1.1 Europe Complement C5 Recombinant Monoclonal Antibody Revenue by Type (2021-2032)
  3. 9.1.2 Europe Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021-2032)
  4. 9.1.3 Europe Complement C5 Recombinant Monoclonal Antibody Price by Type (2021-2032)
  5. 9.2 Europe Complement C5 Recombinant Monoclonal Antibody Market Size by Application
  6. 9.2.1 Europe Complement C5 Recombinant Monoclonal Antibody Revenue by Application (2021-2032)
  7. 9.2.2 Europe Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021-2032)
  8. 9.2.3 Europe Complement C5 Recombinant Monoclonal Antibody Price by Application (2021-2032)
  9. 9.3 Europe Complement C5 Recombinant Monoclonal Antibody Market Size by Country
  10. 9.3.1 Europe Complement C5 Recombinant Monoclonal Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Complement C5 Recombinant Monoclonal Antibody Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Complement C5 Recombinant Monoclonal Antibody Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Complement C5 Recombinant Monoclonal Antibody Market Size by Type
  2. 10.1.1 China Complement C5 Recombinant Monoclonal Antibody Revenue by Type (2021-2032)
  3. 10.1.2 China Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021-2032)
  4. 10.1.3 China Complement C5 Recombinant Monoclonal Antibody Price by Type (2021-2032)
  5. 10.2 China Complement C5 Recombinant Monoclonal Antibody Market Size by Application
  6. 10.2.1 China Complement C5 Recombinant Monoclonal Antibody Revenue by Application (2021-2032)
  7. 10.2.2 China Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021-2032)
  8. 10.2.3 China Complement C5 Recombinant Monoclonal Antibody Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Complement C5 Recombinant Monoclonal Antibody Market Size by Type
  2. 11.1.1 Asia Complement C5 Recombinant Monoclonal Antibody Revenue by Type (2021-2032)
  3. 11.1.2 Asia Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021-2032)
  4. 11.1.3 Asia Complement C5 Recombinant Monoclonal Antibody Price by Type (2021-2032)
  5. 11.2 Asia Complement C5 Recombinant Monoclonal Antibody Market Size by Application
  6. 11.2.1 Asia Complement C5 Recombinant Monoclonal Antibody Revenue by Application (2021-2032)
  7. 11.2.2 Asia Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021-2032)
  8. 11.2.3 Asia Complement C5 Recombinant Monoclonal Antibody Price by Application (2021-2032)
  9. 11.3 Asia Complement C5 Recombinant Monoclonal Antibody Market Size by Country
  10. 11.3.1 Asia Complement C5 Recombinant Monoclonal Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Complement C5 Recombinant Monoclonal Antibody Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Complement C5 Recombinant Monoclonal Antibody Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Complement C5 Recombinant Monoclonal Antibody Market Size by Type
  2. 12.1.1 SAMEA Complement C5 Recombinant Monoclonal Antibody Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Complement C5 Recombinant Monoclonal Antibody Price by Type (2021-2032)
  5. 12.2 SAMEA Complement C5 Recombinant Monoclonal Antibody Market Size by Application
  6. 12.2.1 SAMEA Complement C5 Recombinant Monoclonal Antibody Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Complement C5 Recombinant Monoclonal Antibody Price by Application (2021-2032)
  9. 12.3 SAMEA Complement C5 Recombinant Monoclonal Antibody Market Size by Country
  10. 12.3.1 SAMEA Complement C5 Recombinant Monoclonal Antibody Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Complement C5 Recombinant Monoclonal Antibody Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Complement C5 Recombinant Monoclonal Antibody Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Complement C5 Recombinant Monoclonal Antibody Value Chain Analysis
  2. 13.1.1 Complement C5 Recombinant Monoclonal Antibody Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Complement C5 Recombinant Monoclonal Antibody Production Mode & Process
  6. 13.2 Complement C5 Recombinant Monoclonal Antibody Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Complement C5 Recombinant Monoclonal Antibody Distributors
  9. 13.2.3 Complement C5 Recombinant Monoclonal Antibody Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst